US Stock MarketDetailed Quotes
TTNP Titan Pharmaceuticals
- 3.8350
- +0.6900+21.94%
Close Jan 17 16:00 ET
- 3.9400
- +0.1050+2.74%
Post 19:59 ET
3.51MMarket Cap-0.55P/E (TTM)
3.9700High3.1500Low119.80KVolume3.3050Open3.1450Pre Close417.69KTurnover17.11%Turnover RatioLossP/E (Static)914.23KShares14.800052wk High1.09P/B2.68MFloat Cap3.030052wk Low--Dividend TTM700.06KShs Float1292940.0000Historical High--Div YieldTTM26.07%Amplitude3.0300Historical Low3.4860Avg Price1Lot Size
Titan Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 62.23%-693K | -85.97%-2.07M | 67.72%-613K | 13.33%-7.09M | -42.24%-2.25M | 2.03%-1.84M | 37.07%-1.11M | 35.93%-1.9M | -3.60%-8.18M | -46.07%-1.58M |
| Net income from continuing operations | -125.74%-763K | -31.97%-2.09M | 36.72%-1.06M | 45.43%-5.57M | 23.23%-1.97M | 87.19%-338K | 35.58%-1.59M | 34.06%-1.68M | -16.29%-10.21M | -1.02%-2.57M |
| Operating gains losses | ---- | ---- | ---- | ---1.76M | ---23K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | --0 | -92.31%3K | -95.35%2K | -42.86%112K | -93.33%3K | -43.75%27K | -23.53%39K | -17.31%43K | -11.31%196K | -15.09%45K |
| Other non cash items | --0 | ---1K | ---1K | -94.91%23K | -94.67%24K | ---- | ---- | ---- | 1,358.06%452K | 1,116.22%450K |
| Change In working capital | 134.65%70K | -86.55%23K | 180.07%446K | -342.33%-916K | -156.26%-328K | -214.77%-202K | -57.14%171K | 28.59%-557K | 272.60%378K | -52.33%583K |
| -Change in receivables | 22.22%-14K | --95K | 4,972.22%913K | -113.16%-10K | -176.92%-10K | -134.62%-18K | --0 | 116.98%18K | -90.16%76K | -95.85%13K |
| -Change in inventory | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 434.29%187K | 315.85%354K |
| -Change in prepaid assets | 50.00%69K | -44.00%98K | -20.20%-119K | 7.93%177K | -72.22%55K | 43.75%46K | -18.60%175K | 64.77%-99K | 0.61%164K | -40.54%198K |
| -Change in payables and accrued expense | 106.64%15K | -317.95%-170K | 11.11%-336K | -1,898.00%-899K | -549.40%-373K | -1,638.46%-226K | -73.01%78K | -22.33%-378K | 103.37%50K | -81.39%83K |
| -Change in other working capital | --0 | --0 | 87.76%-12K | -85.86%-184K | --0 | -104.17%-4K | -78.26%-82K | -16.67%-98K | -133.56%-99K | ---65K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 62.23%-693K | -85.97%-2.07M | 67.72%-613K | 13.33%-7.09M | -42.24%-2.25M | 2.03%-1.84M | 37.07%-1.11M | 35.93%-1.9M | -3.60%-8.18M | -46.07%-1.58M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 732K | 504K | 0 | 0 | ||||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---2K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other investing changes | ---- | ---- | ---- | --734K | --506K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --732K | --504K | ---- | ---- | ---- | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 100.64%10M | 406K | -43.63%4.98M | 0 | ||||||
| Net issuance payments of debt | ---- | ---- | ---- | --500K | --0 | ---- | ---- | ---- | --0 | --0 |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -43.67%4.98M | --0 |
| Net preferred stock issuance | ---- | ---- | ---- | --9.5M | --406K | ---- | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --4K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | ---- | 100.64%10M | --406K | ---- | ---- | ---- | -43.63%4.98M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 3,254.10%4.09M | 399.11%6.16M | 116.15%6.77M | -50.52%3.13M | 72.09%8.11M | -98.15%122K | -85.22%1.23M | -50.52%3.13M | 16.98%6.33M | -36.48%4.71M |
| Current changes in cash | -108.68%-693K | -85.97%-2.07M | 67.72%-613K | 213.79%3.64M | 15.39%-1.34M | 526.43%7.99M | 36.96%-1.11M | -194.15%-1.9M | -448.10%-3.2M | -45.40%-1.58M |
| End cash Position | -58.08%3.4M | 3,254.10%4.09M | 399.11%6.16M | 116.18%6.77M | 116.18%6.77M | 72.09%8.11M | -98.15%122K | -85.22%1.23M | -50.52%3.13M | -50.52%3.13M |
| Free cash flow | 62.23%-693K | -85.97%-2.07M | 67.72%-613K | 13.31%-7.09M | -42.37%-2.25M | 2.03%-1.84M | 37.07%-1.11M | 35.93%-1.9M | -3.29%-8.18M | -45.40%-1.58M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
